Principles of hypothesis tests in statistics: Alpha, beta and P;Principes des tests d'hypothese en statisque: α, β et P

Annales Francaises d'Anesthesie et de Reanimation

Volumn 17, Issue 9, 1998, Pages 1168-1180

  Riou, B ^a   Landais, P ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Clinical trial; Hypothese tests; Statistics

Indexed keywords

ARTICLE; CLINICAL RESEARCH; COMPARATIVE STUDY; DATA ANALYSIS; HYPOTHESIS; INTERMETHOD COMPARISON; STATISTICAL ANALYSIS; STATISTICAL CONCEPTS; STATISTICAL PARAMETERS; STATISTICS; ANALYSIS OF VARIANCE; CLINICAL TRIAL; COMPUTER; CONFIDENCE INTERVAL; HUMAN; PATIENT; PROBABILITY; RESEARCH; RISK; SAMPLE SIZE;

ANALYSIS OF VARIANCE; CLINICAL TRIALS; COMPUTERS; CONFIDENCE INTERVALS; DATA INTERPRETATION, STATISTICAL; HUMANS; PATIENTS; PROBABILITY; RESEARCH; RISK; SAMPLE SIZE; STATISTICS;

EID: 0031630224     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0750-7658(00)80015-5     Document Type: Article

References (20)

1. 1 Riou B, Pinaud M. Expression numérique des résultats. Ann Fr Anesth Réanim 1996 ; 15 : 49-56
2. 2 Senn S. Probability, Bayes, P values, Tests of hypotheses and confidence intervals. In: Senn S, ed. Statistical issues in drug development. Chichester: John Wiley & Sons; 1997. p 43-65
3. 3 Falissard B. Les tests d'hypothèses. In: Falissard B, ed. Comprendre et utiliser les statistiques dans les sciences de la vie. Paris: Masson; 1996. p 33-53
4. 4 Ware JH, Mosteller F, Ingelfinger JA. P values. In: Bailar JC, Mosteller F, eds. Medical uses of statistics. Boston: NEJM Books; 1986. p 149-69
5. 5 Pocock SJ. Further aspects of data analysis. In: Pocock SJ, ed. Clinical trials: a practical approach. Chichester: John Wiley & Sons; 1991. p 211-33
6. 6 DeMets DL, Lan KKG. Interim analysis: the alpha spending approach. Stat Med 1994 ; 13 : 1341-52
7. 7 Bauer P. Multiple testing. Stat Med 1991 ; 10 ; 871-90
8. 8 Frison L, Pocock SJ. Repeated measures in clinical trials: analysis using mean summary statistics and its implication for design. Stat Med 1992 ; 11 : 1685-704
9. 9 Altman DG. Matthews JNS. Interaction 1: heterogeneity of effects. Br Med J 1996 ; 313 : 486
10. 10 Matthews JNS, Altman DG. Interaction 3: compare effects size not P values. Br Med J 1996 ; 313 : 808
11. 11 Matthews JNS, Altman DG. Interaction 2: How to examine heterogeneity. Br Med J 1996 ; 313 : 862
12. 12 Falissard B, Landais P. Les statistiques en médecine : et s'il était temps de prendre un peu de distance ? Méd Thér 1995 ; 1 : 775-80
13. 13 Freiman JA, Chalmers TC, Smith H, Kuebler RR. The importance of beta, the type II error, and sample size in the design and interpretation of the randomized controlled trial: survey of two sets of "negative" trials. In: Bailar JC, Mosteller F, eds. Medical uses of statistics. 2nd ed. Boston: NFJM Books; 1992. p 357-73
14. 14 Altman DG. Better reporting of randomised controlled trials: the Consort statement. Br Med J 1996 ; 313 : 570-1
15. 15 Senn S. One-sided and two-sided tests. In: Senn S, ed. Statistical issues in drug development. Chichester: John Wiley & Sons; 1997. p 161-7
16. 16 Ware JH, Antman EM. Equivalence trials. N Engl J Med 1997 ; 33: 1159-61
17. 17 Jones B, Jarvis P, Lewis JA, Ebbut AF. Trials to assess equivalence: the importance of rigourous methods. Br Med J 1996 ; 313 : 36-9
18. 18 Gardner MJ, Altman DG. Confidence intervals rather than P values: estimation rather than hypothesis testing. Br Med J 1986 ; 292: 746-50
19. 19 Daurès JP. Probabilités et statistiques en médecine. Montpellier: Sauramps Médical ; 1993
20. e éd. Paris : Flammarion ; 1969